A Monte Carlo study of cellular S-factors for 1 keV to 1 MeV electrons

Physics in Medicine and Biology

Volumn 54, Issue 16, 2009, Pages 5023-5038

  Bousis, C ^a   Emfietzoglou, D ^a   Hadjidoukas, P ^a   Nikjoo, H ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRON ENERGIES; ELECTRON TRANSPORT; EMITTED ELECTRON; INELASTIC COLLISION; INITIAL ENERGY; INTRACELLULAR LOCALIZATION; MEV-ELECTRONS; MONOENERGETIC ELECTRONS; MONTE CARLO CODES; MONTE CARLO STUDY; PRIMARY ELECTRONS; SOURCE REGION; SPHERICAL VOLUME; SYSTEMATIC STUDY; TARGET REGIONS; TRANSPORT APPROXIMATION;

CYTOLOGY; MONTE CARLO METHODS;

ELECTRONS;

ABSORPTION; ARTICLE; CALCULATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; DOSIMETRY; ELECTRON; ELECTRON TRANSPORT; ENERGY TRANSFER; GEOMETRY; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIUS; SENSITIVITY ANALYSIS; SIMULATION; TECHNIQUE; BIOLOGICAL MODEL; CELL; RADIATION DOSE; RADIATION EXPOSURE; RADIOMETRY;

WATER;

CELL NUCLEUS; CELLS; CYTOPLASM; ELECTRONS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; RADIATION DOSAGE; RADIOMETRY; WATER;

EID: 70349785724     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/54/16/012     Document Type: Article

References (78)

1. Bardiès M, Lame J, Myers M J and Simoen J P 1990 A simplified approach to beta dosimetry for small spheres labelled on the surface Phys. Med. Biol. 35 1039-50 (Pubitemid 20231810)
2. Bardiès M and Pihet P 2000 Dosimetry and microdosimetry of targeted radiotherapy Curr. Pharm. Des. 6 1469-502
3. Baró J, Sempau J, Fernndez-Varea J M and Salvat F 1995 PENELOPE: an algorithm for Monte Carlo simulation of the penetration and energy loss of electrons and positrons in matter Nucl. Instrum. Methods B 100 31-46
4. Berger M J 1963 Monte Carlo calculation of the penetration and diffusion of fast charged particles Methods in Computational Physics vol 1 ed B Alder, S Fernbach and M Rotenberg (New York: Academic) pp 135-215
5. Berger M J, Coursey J S, Zucker M A and Chang J 2005 ESTAR, PSTAR and ASTAR: Computer Programs for Calculating Stopping-Power and Range Tables for Electrons, Protons and Helium Ions (Version 1.2.3) (Gaithersburg, MD: National Institute of Standards and Technology) available at http://physics.nist.gov/Star
6. Bernal M A and Liendo J A 2009 An investigation on the capabilities of the PENELOPE MC code in nanodosimetry Med. Phys. 36 620-5
7. Bolch W E and Kim E-H 1994 Calculations of electron single event distributions for use in internal beta microdosimetry Radiat. Prot. Dosim. 52 77-80
8. Bousis C, Emfietzoglou D, Hadjidoukas P, Nikjoo H and Pathak A 2008a Electron ionization cross-section calculations for liquid water at high impact energies Nucl. Instrum. Methods B 266 1185-92
9. Bousis C, Emfietzoglou D, Hadjidoukas P and Nikjoo H A 2008b A Monte Carlo study of absorbed dose distributions in water in the vapour and liquid phases by intermediate energy electrons: the effect of different condensed-history schemes Phys. Med. Biol. 53 3739-61
10. Bousis C, Emfietzoglou D, Nikjoo H, Hadjidoukas P and Pathak A 2009 The effects of energy-loss straggling and elastic scattering models on Monte Carlo calculations of dose distribution functions for 10 keV to 1 MeV incident electrons in water Nucl. Instrum. Methods B 267 1725-32
11. Brans B, Linden O, Giammarile F, Tennvall J and Punt C 2006 Clinical applications of newer radionuclide therapies Eur. J. Cancer 42 994-1003
12. Buchegger F, Perillo-Adamer F, Dupertuis Y M and Delaloye A B 2006 Auger radiation targeted into DNA: a therapy perspective Eur. J. Nucl. Med. Mol. Imaging 33 1352-63
13. 131I in spheres of various sizes J. Nucl. Med. 49 151-7
14. Chauvie S, Francis Z, Guatelli S, Incerti S, Mascialino B, Moretto P, Nieminen P and Pia M G 2007 Geant4 physics processes for microdosimetry simulation: design foundation and implementation of the first set of models IEEE Trans. Nucl. Sci. 54 2619-28
15. Cole A 1969 Absorption of 20-eV to 50,000-eV electron beams in air and plastic Radiat. Res. 38 7-33
16. Coulot J, Ricard M and Aubert B 2003 Validation of the EGS usercode DOSE3D for internal beta dose calculation at the cellular and tissue levels Phys. Med. Biol. 48 2591-602
17. Davis T et al 2003 Long-term results of a randomized trial comparing tositumomab and iodine-131 Tositumomab (BEXXAR) with tositumomab alone in patients with relapsed or refractory low grade (LG) or transformed low grade (T-LG) non-Hodgkin's lymphoma (NHL) Blood 102 A405-6
18. Delaney G, Jacob S, Featherstone C and Barton M 2005 The role of radiotherapy in cancer treatment Cancer 104 1129-37
19. Emfietzoglou D, Bousis C, Hindorf C, Fotopoulos A, Pathak A and Kostarelos K 2007 A Monte Carlo study of energy deposition at the sub-cellular level for application to targeted radionuclide therapy with low-energy electron emitters Nucl. Instrum. Methods B 256 547-53
20. Emfietzoglou D, Kostarelos K, Hadjidoukas P, Bousis C, Fotopoulos A, Pathak A and Nikjoo H 2008 Subcellular S-factors for low-energy electrons: a comparison of Monte Carlo simulations and continuous-slowing-down calculations Int. J. Radiat. Biol. 84 1034-44
21. Emfietzoglou D, Papamichael G, Kostarelos K and Moschovitch M 2000 A Monte Carlo track structure code for electrons (∼10 eV-10 keV) and protons (∼0.3-10 MeV) in water: partitioning of energy and collision events Phys. Med. Biol. 45 3171-94
22. 201Tl Eur. J. Nucl. Med. 25 205-14
23. Fernndez-Varea J M, Salvat F, Dingfelder M and Liljequist D 2005 A relativistic optical-data model for inelastic scattering of electrons and positrons in condensed matter Nucl. Instrum. Methods B 229 187-218
24. Ftnikov S and Böhm R 2000a Monte Carlo calculations of energy deposition in DNA for Auger emitters Radiat. Prot. Dosim. 92 269-78
25. Ftnikov S and Böhm R 2000b Monte Carlo calculations of energy deposition on cellular, multicellular and organ level for Auger emitters Radiat. Prot. Dosim. 92 279-88
26. Gardin I, Faraggi M, Hue E and Bok B D 1995 Modelling of the relationship between cell dimensions and mean electron dose delivered to the cell nucleus: application to five radionuclides used in nuclear medicine Phys. Med. Biol. 40 1001-14
27. Goddu S M, Howell R W and Rao D V 1994a Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments J. Nucl. Med. 35 303-16
28. Goddu S M, Howell R G, Bouchet L G, Bolch W E and Rao D V 1997 MIRD Cellular S Values (Reston, VA: Society of Nuclear Medicine)
29. Goddu S M, Rao D V and Howell R W 1994b Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides J. Nucl. Med. 35 521-30
30. Gordon L I, Molina A, Witzig T, Emmanouilides C, Raubitschek A, Darif M, Schilder R J, Wiseman G and White C A 2004 Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20 B-cell lymphoma: long term follow-up of a phase I/II study Blood 103 4429-31
31. 131I labeled ligands or antibodies Int. J. Radiat. Oncol. Biol. Phys. 46 1025-36
32. Hindorf C, Emfietzoglou D, Linden O, Bousis C, Fotopoulos A, Kostarelos K and Flux G D 2007 Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread Cancer Biother. Radiopharm. 22 357-66
33. Hindorf C, Emfietzoglou D, Linden O, Kostarelos K and Strand S-E 2005 Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma Cancer Biother. Radiopharm. 20 224-30
34. Howell R W 1994 The MIRD Schema: from organ to cellular dimensions J. Nucl. Med. 35 531-33
35. Howell R W, Rao D V and Sastry K S R 1989 Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors Med. Phys. 16 66-74
36. Hsiao Y and Stewart R D 2008 Monte Carlo simulation of DNA damage induction by x-rays and selected radioisotopes Phys. Med. Biol. 53 233-44
37. Humm J L, Roeske J C, Fisher D R and Chen G T Y 1993 Microdosimetry concepts in radioimmunotherapy Med. Phys. 20 535-41
38. Humm L R 1986 Dosimetric aspects of radiolabeled antibodies for tumor therapy J. Nucl. Med. 27 1490-7
39. ICRU 1979 Methods of Assessment of Absorbed Dose in Clinical Use of Radionuclides ICRU Report 32 (Bethesda, MD: ICRU)
40. ICRU 1984 Stopping Powers for Electrons and Positrons ICRU Report 37 (Bethesda, MD: ICRU)
41. Jablonski A, Salvat F and Powell C J 2003 NIST Electron Elastic-Scattering Cross-Section Database Version 3.1 (Gaithersburg, MD: National Institute of Standards and Technology)
42. Jhanwar Y S and Divgi C 2005 Current status of therapy of solid tumors J. Nucl. Med. 46 141 S-150S
43. Johnson T A and Press O W 2000 Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience Ann. Hematol. 79 175-82
44. Jungerman J A, Yu K H P and Zanelli C I 1984 Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy Int. J. Appl. Radiat. Isot. 35 883-8
45. 131I-tositumomab therapy as initial treatment for follicular lymphoma N. Engl. J. Med. 352 441-9
46. Kassis A I 1992 The MIRD approach: remembering the limitations J. Nucl. Med. 33 781-2
47. Kassis A I and Adelstein S J 2004 Radiobiologic principles in radionuclide therapy J. Nucl. Med. 46 4S-12S
48. Kawrakow I 2000 Accurate condensed history Monte Carlo simulation of electron transport: I. EGSnrc, the new EGS4 version Med. Phys. 27 485-98 (Pubitemid 30171797)
49. Kim Y K, Santos J P and Parente F 2000 Extension of the binary-encounter-dipole model to relativistic incident electrons Phys. Rev. A 62 1-14
50. 33P radionuclide cocktail Phys. Med. Biol. 53 1961-74
51. 125I in and around water spheres simulating micrometastases of differentiated thyroid cancer Radiat. Res. 156 419-29
52. Loevinger R, Budinger T F and Watson E E 1991 MIRD Primer for Absorbed Dose Calculations (New York: Society of Nuclear Medicine)
53. Mainardi E, Donahue R J, Wilson W E and Blakely E A 2004 Comparison of microdosimetric simulations using PENELOPE and PITS for a 25 keV electron microbeam in water Radiat. Res. 162 326-31
54. McKinley W A and Feshbach H 1948 The Coulomb scattering of relativistic electrons by nuclei Phys. Rev. 74 1759-63
55. Milenic D E, Brady E D and Brechbiel M W 2004 Antibody-targeted radiation cancer therapy Nat. Rev. 3 488-98
56. Nahum A E 1996 Microdosimetry and radiocurability: modelling targeted therapy with β-emitters Phys. Med. Biol. 41 1957-72
57. Nikjoo H, Terrissol M, Hamm R N, Turner J E, Uehara S, Paretzke H G and Goodhead D T 1994 Comparison of energy deposition in small cylindrical volumes by electrons generated by Monte Carlo track structure codes for gaseous and liquid water Radiat. Prot. Dosim. 52 165-9
58. O'Donoghue J A, Bardiès M and Wheldon T E 1995 Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides J. Nucl. Med. 36 1902-9
59. Pacilio M, Lanconelli N, Lo Meo S, Betti M, Montani L, Torres Aroche L A and M A 2009 Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations Med. Phys. 36 1543-52
60. Press O W et al 1995 Phase II trial of I-131-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas Lancet 346 336-40
61. Rogers D W and Bielajew A F 1988 A comparison of EGS and ETRAN Monte Carlo Transport of Electrons and Photons below 50 MeV ed T M Jenkins et al (New York: Plenum) pp 323-44
62. Salvat F, Fernndez-Varea J M and Sempau J 2003 PENELOPE: a code system for Monte Carlo simulation of electron and photon transport Workshop Proc. (Issy-les-Moulineaux: OECD/NEA) http://www.nea.fr/html/dbprog/peneloperef.html
63. Sastry K S R, Haydock C, Basha A M and Rao D V 1985 Electron dosimetry for radioimmunotherapy: optimal electron energy Radiat. Prot. Dosim. 13 249-52
64. Sgouros G 1995 Radioimmunotherapy of micrometastasis: sidestepping the solid-tumor hurdle J. Nucl. Med. 36 1910-2
65. Sgouros G 2008 Alpha-particles for targeted therapy Adv. Drug Del. Rev. 60 1402-6
66. Stabin M G 2006 Nuclear medicine dosimetry Phys. Med. Biol. 51 R187-202
67. Stabin M G and Konijnenberg M W 2000 Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes J. Nucl. Med. 41 149-60
68. Stewart R D, Wilson W E, McDonald J C and Strom D J 2002 Microdosimetric properties of ionizing electrons in water: a test of the PENELOPE code system Phys. Med. Biol. 47 79-88
69. Syme A M, Kirkby C, Riauka T A, Fallone B G and McQuarrie S A 2004 Monte Carlo investigation of single cell beta dosimetry for intraperitoneal radionuclide therapy Phys. Med. Biol. 49 1959-72
70. 60Co γ-rays, electrons, protons and light ions Phys. Med. Biol. 47 1303-19
71. Torres-García E, Garnica-Garza H M and Ferro-Flores G 2006 Monte Carlo microdosimetry of Re-188- and I-131-labelled anti-CD20 Phys. Med. Biol. 51 N349-56
72. Tung C J, Chao T C, Hsieh H W and Chan W T 2007 Low-energy electron interactions with liquid water and energy depositions in nanometric volumes Nucl. Instrum. Methods B 262 231-39
73. Tung C J, Liu C S, Wang J P and Chang S L 2004 Calculations of cellular microdosimetry parameters for alpha particles and electrons Appl. Radiat. Isot. 61 739-43
74. 186Re as a function of tumor size, uptake, and intracellular distribution Int. J. Radiat. Oncol. Biol. Phys. 36 197-204
75. Wheldon T E and O'Donoghue J A 1990 The radiobiology of targeted radiotherapy Int. J. Radiat. Biol. 58 1-21
76. 90Y Radiother. Oncol. 21 91-9
77. Wiseman G et al 2001 Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma Crit. Rev. Oncol. Hematol. 39 181-94
78. Witzig T E et al 2002 Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma J. Clin. Oncol. 20 2453-63